Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
about
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor statusBreastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysisPrevention of breast cancer in postmenopausal women: approaches to estimating and reducing riskGenome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.Mammographic breast density as a risk factor for breast cancer: awareness in a recently screened clinical sample.Association between oestrogens receptor expressions in breast cancer and comorbidities: a cross-sectional, population-based study.Effect of changing breast cancer incidence rates on the calibration of the Gail model.Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese womenBaseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivorsAssessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).Emerging Concepts in Breast Cancer Risk Prediction.Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancersRisk factor modification and projections of absolute breast cancer riskTamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study.Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer PatientsAt risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis predictionRecalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort studySoy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.Validation of a breast cancer risk prediction model developed for Black women.Consumption of dairy and meat in relation to breast cancer risk in the Black Women's Health Study.Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trialsPhysical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study.Evaluating breast cancer risk projections for Hispanic women.Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal womenRisk prediction models of breast cancer: a systematic review of model performances.Development and validation of risk models and molecular diagnostics to permit personalized management of cancer.Development of a risk assessment tool for projecting individualized probabilities of developing breast cancer for Chinese women.Family history and risk of breast cancer: an analysis accounting for family structureRisk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition.Genetic and environmental factors and serum hormones, and risk of estrogen receptor-positive breast cancer in pre- and postmenopausal Japanese women.
P2860
Q27012792-08E5FDAD-A751-40D9-B64F-C729F0BFFCF2Q28085555-CF0AF0EB-859D-44A6-883A-1C6EA97581FEQ28390064-29A8989F-8541-4A0F-AA59-D3BCFB4B6EBDQ29417100-D44EB5D8-8F7A-4AB9-9495-7FB0548DDB3BQ30238753-CA996B1E-41F7-44F9-B95A-CA1046C1BA99Q33573827-93C477E6-E5C2-4941-91D4-0A579D106DE6Q33645985-0CE1C5ED-D293-4B81-85BA-E3D841783B33Q33897605-C48F2612-92AC-41EF-8DF3-A694C85004AFQ33965090-BF9A7DC5-0073-449E-9300-853C32BF7FBBQ34039859-98E6BAA1-0C7B-45B5-AA57-82D25A48A689Q34048111-04F0F66E-7C4B-49E7-967A-DA789E73FFFFQ34267477-2F0E90AF-FF73-48D7-9155-CF445668B2E0Q34442127-277638E4-0108-4548-9019-C75189E8FB54Q34481239-318A3BAF-65D9-427F-8196-85F751DAD787Q34670325-D133EB92-33FC-46AE-BC5A-31EDE1BEB058Q34764884-44DC33FF-40AB-40E5-9EF4-D861595669B4Q35090578-1065CD10-E33D-40E8-BD53-C6710AEE4259Q35528912-D1DD2EC1-FFD4-432F-BF28-D5984BEC2A93Q35592002-AD88F174-CDEE-407D-AA0E-FABB51A96A04Q36112872-A345DC7D-2F46-457C-94DC-211B3F190F56Q36118724-9BC68F5E-A066-4BB3-AFA6-17B012C7BB86Q36649796-23E97AF1-33F8-4503-8440-6ED06599E1EDQ36744585-B0ED0D96-9316-4482-B4CD-C542C77551B7Q36896822-F0CAB711-9639-48D9-BECA-194CEED7119EQ36953551-7F85FFE0-D5CA-477D-B081-513EACCF17ECQ36963677-A8F5CC8B-98B5-4889-A690-8A06A58DAAFCQ36971892-7E923A15-75DE-4624-AC90-170A13FE1AC1Q37186471-D2CDD6A5-D9C4-4F78-BE51-FEA854001ED2Q37307773-A0868FFD-3DB4-41F1-BEB2-10209B3EFCFCQ37353842-35E04EE2-6BB1-473E-B7D3-34B81B0FBB8EQ37355998-6169F670-0D55-4F61-AE12-7C2CCC69D1E5Q37955078-59AE9EB1-07F3-4C0D-938D-148C1D7D939EQ38151510-783F4D50-3E89-4C1C-97FB-6DA5A160B0F7Q38236180-A2A577F2-E9F6-4C98-9C5A-6C1A527B0D8DQ38746332-E5E657FA-3FE3-4F63-B697-03ECC1678A68Q39045823-F2C4A06B-C131-4B80-87F2-BE8D5B807B53Q39214999-9596304A-0405-429F-97E1-169F0AABDF9EQ40498027-5985FDD9-E6C3-423F-A427-1BF0F839529EQ41442965-358A139B-2247-4874-81BF-7FFB19C6DCEFQ42371580-C539F9D6-A0E8-4040-B640-53AC78A3AB48
P2860
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
@en
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
@nl
type
label
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
@en
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
@nl
prefLabel
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
@en
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
@nl
P2093
P2860
P356
P1476
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
@en
P2093
Aaron K Aragaki
Carol A Rosenberg
Dorothy S Lane
F Allan Hubbell
Garnet L Anderson
Gloria Sarto
Rowan T Chlebowski
Shagufta Yasmeen
Thomas Rohan
Women's Health Initiative Investigators
P2860
P304
P356
10.1093/JNCI/DJM224
P407
P577
2007-11-13T00:00:00Z